K. Winther

3.9k total citations
131 papers, 3.1k citations indexed

About

K. Winther is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, K. Winther has authored 131 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 26 papers in Endocrinology, Diabetes and Metabolism and 20 papers in Pharmacology. Recurrent topics in K. Winther's work include Antiplatelet Therapy and Cardiovascular Diseases (22 papers), Hormonal and reproductive studies (12 papers) and Pharmacology and Obesity Treatment (10 papers). K. Winther is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (22 papers), Hormonal and reproductive studies (12 papers) and Pharmacology and Obesity Treatment (10 papers). K. Winther collaborates with scholars based in Denmark, Sweden and United States. K. Winther's co-authors include G. Gleerup, A. Kharazmi, Oluf Pedersen, J. O. Clausen, C. Hedman, Jesper Mehlsen, K. Borch‐Johnsen, P. Hougaard, Hans Ibsen and Richard N. Bergman and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Diabetes Care.

In The Last Decade

K. Winther

130 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Winther Denmark 29 696 577 570 557 403 131 3.1k
Jane McEneny United Kingdom 35 669 1.0× 674 1.2× 601 1.1× 403 0.7× 429 1.1× 99 3.5k
Antonio Gambardella Italy 33 774 1.1× 887 1.5× 524 0.9× 759 1.4× 456 1.1× 67 3.0k
Domenico Lapenna Italy 38 1.4k 2.1× 742 1.3× 538 0.9× 322 0.6× 881 2.2× 125 4.6k
Lukas E. Spieker Switzerland 23 1.6k 2.4× 763 1.3× 419 0.7× 549 1.0× 723 1.8× 42 3.6k
Gregorio Caimi Italy 28 656 0.9× 851 1.5× 498 0.9× 401 0.7× 360 0.9× 222 3.1k
Elisardo C. Vasquez Brazil 30 802 1.2× 909 1.6× 745 1.3× 329 0.6× 290 0.7× 125 3.0k
Felice D’Onofrio Italy 25 503 0.7× 606 1.1× 496 0.9× 711 1.3× 328 0.8× 50 2.2k
M Varricchio Italy 43 1.3k 1.9× 1.3k 2.3× 770 1.4× 1.2k 2.2× 644 1.6× 107 5.0k
Silvana S. Meyrelles Brazil 29 592 0.9× 572 1.0× 766 1.3× 329 0.6× 237 0.6× 104 2.7k
Maria Assunta Potenza Italy 24 455 0.7× 701 1.2× 708 1.2× 311 0.6× 216 0.5× 61 2.4k

Countries citing papers authored by K. Winther

Since Specialization
Citations

This map shows the geographic impact of K. Winther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Winther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Winther more than expected).

Fields of papers citing papers by K. Winther

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Winther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Winther. The network helps show where K. Winther may publish in the future.

Co-authorship network of co-authors of K. Winther

This figure shows the co-authorship network connecting the top 25 collaborators of K. Winther. A scholar is included among the top collaborators of K. Winther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Winther. K. Winther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campbell-Tofte, Joan, et al.. (2024). Standardization parameters and synergism of source plant materials for the antidiabetic efficacy of the Rauvolfia-Citrus tea. Fitoterapia. 176. 106004–106004. 1 indexed citations
2.
3.
4.
5.
Kharazmi, A., et al.. (2013). The anti-inflammatory capacity of Rose-hip is strongly dependent on the seeds - a comparison of animal and human studies. Osteoarthritis and Cartilage. 21. S216–S217. 6 indexed citations
6.
Reinhard, Henrik, Mads Nybo, Peter Riis Hansen, et al.. (2011). Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria. Cardiovascular Diabetology. 10(1). 70–70. 15 indexed citations
7.
Christensen, P., Else Marie Bartels, B.F. Riecke, et al.. (2011). Improved nutritional status and bone health after diet-induced weight loss in sedentary osteoarthritis patients: a prospective cohort study. European Journal of Clinical Nutrition. 66(4). 504–509. 25 indexed citations
8.
Engelen, Lian, Søren S. Lund, Isabel Ferreira, et al.. (2011). Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes. European Journal of Endocrinology. 164(3). 371–379. 17 indexed citations
9.
Spohr, Camilla, Charlotte Brøns, K. Winther, J. Dyerberg, & Allan Vaag. (2005). No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus. Platelets. 16(5). 301–305. 23 indexed citations
10.
11.
Mehlsen, Jesper, et al.. (2002). Effects of a Ginkgo biloba extract on forearm haemodynamics in healthy volunteers. Clinical Physiology and Functional Imaging. 22(6). 375–378. 37 indexed citations
12.
Kharazmi, Arsalan & K. Winther. (1999). Rose hip inhibits chemotaxis and chemiluminescence of human peripheral blood neutrophils in vitro and reduces certain inflammatory parameters in vivo. Inflammopharmacology. 7(4). 377–386. 60 indexed citations
13.
Jeppesen, Lise Leth, Kirk C. Wilhelmsen, Lars B. Nielsen, et al.. (1998). An Insertion/Deletion polymorphism in the promoter region of the plasminogen activator inhibitor-1 gene is associated with plasma levels but not with stroke risk in the elderly. Journal of Stroke and Cerebrovascular Diseases. 7(6). 385–390. 6 indexed citations
14.
Gleerup, G. & K. Winther. (1996). Smoking further increases platelet activity in patients with mild hypertension. European Journal of Clinical Investigation. 26(1). 49–52. 19 indexed citations
15.
Clausen, J. O., Torben Hansen, Christian Bjørbæk, et al.. (1995). Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. The Lancet. 346(8972). 397–402. 172 indexed citations
16.
Gleerup, G., Jesper Vind, & K. Winther. (1995). Platelet function and fibrinolytic activity during rest and exercise in borderline hypertensive patients. European Journal of Clinical Investigation. 25(4). 266–270. 22 indexed citations
17.
Pedersen, A. K., et al.. (1990). LongoVital in the prevention of recurrent aphthous ulceration. Journal of Oral Pathology and Medicine. 19(8). 371–375. 30 indexed citations
18.
Winther, K., C. Hedman, & Hans Flodgaard. (1990). Platelet P1, P4‐Di (adenosine‐51) tetraphosphate (AP4A) in migraine patients before and during β‐adrenoceptor blockade. European Journal of Clinical Investigation. 20(3). 336–338. 2 indexed citations
19.
Hedner, Thomas, Ove K. Andersson, K. Winther, & Bertil Persson. (1988). Are There Reasons to Believe That the Antihypertensive Effects of Serotonin (S2) Antagonists Are Age-Related?. Journal of Cardiovascular Pharmacology. 12(Supplement). S132–S140. 2 indexed citations
20.
Oxholm, P., K. Winther, & R. Manthorpe. (1986). Platelets in Blood and Salivary Glands of Patients with Primary Sjögren’s Syndrome. Scandinavian Journal of Rheumatology. 15(sup61). 170–172. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane McEneny Breakdown of academic impact, for papers by Antonio Gambardella Breakdown of academic impact, for papers by Domenico Lapenna Breakdown of academic impact, for papers by Lukas E. Spieker Breakdown of academic impact, for papers by Gregorio Caimi Breakdown of academic impact, for papers by Elisardo C. Vasquez Breakdown of academic impact, for papers by Felice D’Onofrio Breakdown of academic impact, for papers by M Varricchio Breakdown of academic impact, for papers by Silvana S. Meyrelles Breakdown of academic impact, for papers by Maria Assunta Potenza
Rankless by CCL
2026